Sponsored Content
The application of a phase-appropriate quality-by-design (QbD) framework increases the understanding of the interplay between the process parameters of spray drying and product quality that, when applied during scale-up, increases the chances of a successful outcome of the commercial manufacturing process. Live: Tuesday, November 19, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET On demand available after airing until Nov. 19, 2020 Register free
Register free: http://www.pharmtech.com/pt_w/scale_up
Event Overview:
The use of spray drying to manufacture amorphous dispersions is continuing to grow due to the number of drug candidates exhibiting poor solubility. Nearly 40% of the new chemical entities (NCEs) screened by pharmaceutical companies fail to progress to later stages of development due to poor aqueous solubility. 1 The application of a phase-appropriate quality-by-design (QbD) framework increases the understanding of the interplay between the process parameters of spray drying and product quality that, when applied during scale-up, increases the chances of a successful outcome of the commercial manufacturing process.
1 Roots Analysis Business Research & Consulting, Pharmaceutical Spray Drying Market, 2nd edition, 2018-2028.
Key Learning Objectives:
Speakers: Ryan Minikis, Principal, Arclight Pharmaceuticals, LLC
Jon Scrafford, Director, Engineering & Continuous Improvement, Catalent
Time and date: Tuesday, Nov. 19, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET
On demand available after airing until Nov. 19, 2020
Sponsor: Catalent
Register free: http://www.pharmtech.com/pt_w/scale_up